ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 32 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,000 | -77.8% | 1,900 | -67.2% | 0.00% | -71.4% |
| Q1 2017 | $9,000 | +12.5% | 5,800 | +3.6% | 0.01% | +40.0% |
| Q3 2016 | $8,000 | -38.5% | 5,600 | -24.3% | 0.01% | -50.0% |
| Q2 2016 | $13,000 | +550.0% | 7,400 | +572.7% | 0.01% | +900.0% |
| Q1 2016 | $2,000 | – | 1,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,590,267 | $915,000 | 0.48% |
| ARMISTICE CAPITAL, LLC | 4,382,000 | $2,520,000 | 0.30% |
| DAFNA Capital Management LLC | 333,000 | $192,000 | 0.12% |
| SABBY MANAGEMENT, LLC | 2,434,103 | $1,400,000 | 0.09% |
| Anson Funds Management LP | 1,024,592 | $589,000 | 0.09% |
| Hartford Financial Management Inc. | 18,000 | $10,000 | 0.01% |
| Summit X, LLC | 11,000 | $7,000 | 0.01% |
| SNS Financial Group, LLC | 18,000 | $10,000 | 0.00% |
| DOWLING & YAHNKE LLC | 22,870 | $13,000 | 0.00% |
| A.R.T. Advisors, LLC | 30,005 | $17,000 | 0.00% |